Annie M. Wong
Melbourne, VIC, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
General practitioners' attitudes towards liquid biopsy as a diagnostic test for advanced lung cancer.
Journal: The journal of liquid biopsy
Published: August 21, 2025
Pembrolizumab-related toxicity in patients with advanced melanoma.
Journal: The New Zealand medical journal
Published: June 26, 2025
Biomarkers for immunotherapy resistance in non-small cell lung cancer.
Journal: Frontiers in oncology
Published: September 02, 2024
Real-World Outcomes of Immunotherapy for Melanoma Brain Metastases in New Zealand.
Journal: JCO oncology practice
Published: July 25, 2024
Pembrolizumab-induced Myasthenia Gravis: Literature Review of Ocular Manifestations and a Refractory Case.
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)
Published: September 11, 2021
Second-line immunotherapy in patients with metastatic melanoma.
Journal: The Lancet. Oncology
Published: March 15, 2021
γδ T Cells in Merkel Cell Carcinomas Have a Proinflammatory Profile Prognostic of Patient Survival.
Journal: Cancer immunology research
Published: October 01, 2020
18F-FDG PET/CT based spleen to liver ratio associates with clinical outcome to ipilimumab in patients with metastatic melanoma.
Journal: Cancer imaging : the official publication of the International Cancer Imaging Society
Published: November 16, 2019
Balancing the Hype with Reality: What Do Patients with Advanced Melanoma Consider When Making the Decision to Have Immunotherapy?
Journal: The oncologist
Published: November 26, 2018
Outcomes of Australian patients receiving non-funded anti-PD-1 immune checkpoint inhibitors for non-melanoma cancers.
Journal: Asia-Pacific journal of clinical oncology
Published: September 29, 2017
Efficacy of anti-PD-1 therapy in patients with melanoma brain metastases.
Journal: British journal of cancer
Published: April 06, 2017
Last Updated: 09/26/2026